相关实验视频
Updated: Jan 27, 2026

10:02
Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
15.3K
在儿科患者中使用EUS
Christoph F Dietrich1, Barbara Braden2, Kathleen Möller3
1Department General Internal Medicine (DAIM), Hospitals Hirslanden Bern Beau Site, Salem and Permanence, Bern, Switzerland.
Endoscopic ultrasound
|January 26, 2026
概括
内镜超声波 (EUS) 为儿科胃肠道疾病提供高分辨率,无辐射的成像. 增加培训和可用性至关重要,以克服使用不足,并改善儿科患者的护理.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 医疗成像医学成像
- 诊断内镜检查 诊断内镜检查
背景情况:
- 内镜超声波 (EUS) 是儿科胃肠病学中一个有价值的工具.
- 它提供胃肠道和相邻器官的高分辨率成像.
- 尤斯在没有辐射暴露的情况下诊断腹部疾病时特别有用.
研究的目的:
- 对儿科患者EUS的临床应用和结果进行审查.
- 突出EUS在儿科胃肠道,胰腺,胆道和肠道疾病中的诊断和治疗潜力.
- 解决儿科护理中EUS未充分利用的问题.
主要方法:
- 关于EUS在儿科胃肠病学中的临床应用和结果的文献综述.
- 分析EUS在诊断和管理各种儿科疾病中的有效性.
- 识别儿童使用EUS的挑战和障碍.
主要成果:
- 欧盟医疗系统 (EUS) 展示了对儿科腹部疾病的准确性和高分辨率成像能力.
- 它为其他成像方式提供了一个无辐射的替代方案.
- 尽管已被证明是有效的,但由于技术挑战和缺乏专业专业知识,EUS在儿科环境中尚未得到充分利用.
结论:
- EUS是儿科胃肠病学中必不可少的,有效的成像工具.
- 提高儿科EUS的可用性和专业培训至关重要.
- 增加对儿科EUS的访问将改善儿童的诊断精度和治疗结果.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution
276
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
Pharmacokinetics in Pediatric Patients: Drug Metabolism
203
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
203
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
262
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
262
Patient-centered Care
2.9K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.9K
Drug Dosing: Obese Patients
238
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
238

